Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Itrifal Hakim Ali (Oral) and Habb-e- Kalaf (topical, mix the pills in Aab-e-Lemu): Itrifal Hakim Ali in the dose of 10gm once daily and they will also be advised to apply Habb-e- Kalaf
Sponsors
National Research Institute of Unani Medicine for Skin Disorders Hyderabad
Eligibility
Inclusion criteria
Inclusion criteria: Participants of any sex aged 19-60 years Participant having any of the sign and symptoms of Bahaq Hypopigmented macule Hyperpigmented macule Erythema Pruritus on the lesion Scaling / Desquamation and Presence of Malassezia furfurin the scrapings of the lesion
Exclusion criteria
Exclusion criteria: Participant with serious co-morbid medical condition and other fungal infection Participant who had received any systemic or topical antimycotic therapy within month of start of study Pregnant or Lactating Women Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction Known cases of Immunocompromised states (HIV/ AIDS, etc.)/ Malignancies Participant not willing to attend treatment schedule regularly
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of Response to Therapy: Clinical assessment will be done at 0,2, 4, 6weeks and the response to treatment will be assessed using the following parameters: 1.Total sign and symptoms score (TSSS) 2.Investigator Global assessment 3.KOH examination: 4. Fungus Culture: if possible in 5 participantsâ?? Timepoint: outcomes will be assessed at baseline,2 weeks, 4 weeks and at 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Lab investigationTimepoint: 0 and 6 weeks | — |
Countries
India
Contacts
Public ContactProf Qamar Uddin
National Research Institute of Unani Medicine for Skin Disorders, Hyderabad
Outcome results
None listed